| abstract |
Provided herein are compounds of formula I: And its tautomers and pharmaceutically acceptable salts and solvates, wherein R 1 and R 2 have the meanings given in the description, they are inhibitors of RET kinase and are suitable for the treatment and prevention of available RET kinase Diseases treated with inhibitors, including RET-related diseases and disorders. |